DrugPatentWatch Database Preview
Biologic Drugs With Dosage Form: GEL; TOPICAL
» See Plans and Pricing
Details for Dosage Type: GEL; TOPICAL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | Ethicon, Inc. (Somerville, NJ) | 2012-10-10 | RX | company | |
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | LTS Lohamann Therapie-Systeme AG (Andernach, DE) | 2019-06-04 | RX | search | |
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | University of Louisville Research Foundation, Inc. (Louisville, KY) | 2022-05-14 | RX | search | |
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | University of Louisville Research Foundation, Inc. (Louisville, KY) | 2022-05-14 | RX | search | |
| Smith And Nephew | REGRANEX | becaplermin | GEL; TOPICAL | 103691 | 001 | 1997-12-16 | Start Trial | Momenta Pharmaceuticals, Inc. (Cambridge, MA) | 2023-10-01 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
